Vertex Pharmaceuticals (VRTX)

Depreciation & Amortization

$56.50M

Quarterly · Period ending: · USD

VRTX logo

VRTX Depreciation & Amortization

Latest reported$56.50M
VRTX Quarterly Depreciation & Amortization ($400.00K → $56.50M)
High-resolution chart · PNG

VRTX depreciation & amortization history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Depreciation & Amortization — Quarterly (USD)
Period endingDepreciation & Amortization (USD)
3,059,000
2,523,000
2,696,000
2,314,000
2,110,000
1,975,000
2,000,000
1,700,000
1,400,000
1,200,000
1,400,000
1,100,000
1,100,000
900,000
1,000,000
1,000,000
800,000
800,000
700,000
800,000
900,000
800,000
1,000,000
1,000,000
700,000
1,000,000
1,000,000
700,000
900,000
900,000
1,100,000
900,000
1,100,000
800,000
700,000
700,000
800,000
600,000
500,000
400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.